| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| LLY - Eli Lilly and Company | HOLD | 0 @ USD 839.96 | USD 0 | The current share valuation price of LLY based on adjusted close was USD 839.96. The average price that LLY shares were previous bought at was USD 860.406. The current market price is -2.4% lower than average price they were purchased at. The value of the holding in LLY has increased by USD 5,796,160 compared to the previous valuation of Eli Lilly and Company however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| NOVN.SW - | HOLD | 0 @ CHF 110.531 | CHF 0 | The current share valuation price of NOVN.SW based on adjusted close was CHF 110.531. The average price that NOVN.SW shares were previous bought at was CHF 106.743. The current market price is 3.5% higher than average price they were purchased at. The value of the holding in NOVN.SW has fallen by CHF 107,390 (USD $131,969) compared to the previous valuation of |
| GILD - Guild Esports Plc | HOLD | 0 @ USD 104.54 | USD 0 | The current share valuation price of GILD based on adjusted close was USD 104.54. The average price that GILD shares were previous bought at was USD 106.149. The current market price is -1.5% lower than average price they were purchased at. The value of the holding in GILD has fallen by USD 72,033 compared to the previous valuation of Guild Esports Plc |
| AMGN - Amgen Inc | HOLD | 0 @ USD 277.29 | USD 0 | The current share valuation price of AMGN based on adjusted close was USD 277.29. The average price that AMGN shares were previous bought at was USD 306.86. The current market price is -9.6% lower than average price they were purchased at. The value of the holding in AMGN has fallen by USD 57,962 compared to the previous valuation of Amgen Inc |
| VRTX - Vertex Pharmaceuticals Inc | HOLD | 0 @ USD 489.1 | USD 0 | The current share valuation price of VRTX based on adjusted close was USD 489.1. The average price that VRTX shares were previous bought at was USD 504.337. The current market price is -3.0% lower than average price they were purchased at. The value of the holding in VRTX has increased by USD 144,444 compared to the previous valuation of Vertex Pharmaceuticals Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| MCK - McKesson Corporation | HOLD | 0 @ USD 697.08 | USD 0 | The current share valuation price of MCK based on adjusted close was USD 697.08. The average price that MCK shares were previous bought at was USD 651.544. The current market price is 7.0% higher than average price they were purchased at. The value of the holding in MCK has increased by USD 70,193 compared to the previous valuation of McKesson Corporation however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| CI - Cigna Corp | HOLD | 0 @ USD 330.13 | USD 0 | The current share valuation price of CI based on adjusted close was USD 330.13. The average price that CI shares were previous bought at was USD 315.31. The current market price is 4.7% higher than average price they were purchased at. The value of the holding in CI has increased by USD 41,289 compared to the previous valuation of Cigna Corp however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| ZTS - Zoetis Inc | HOLD | 0 @ USD 148.67 | USD 0 | The current share valuation price of ZTS based on adjusted close was USD 148.67. The average price that ZTS shares were previous bought at was USD 163.479. The current market price is -9.1% lower than average price they were purchased at. The value of the holding in ZTS has increased by USD 197,335 compared to the previous valuation of Zoetis Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| ELV - Elevance Health Inc | HOLD | 0 @ USD 424.53 | USD 0 | The current share valuation price of ELV based on adjusted close was USD 424.53. The average price that ELV shares were previous bought at was USD 408.28. The current market price is 4.0% higher than average price they were purchased at. The value of the holding in ELV has fallen by USD 513,203 compared to the previous valuation of Elevance Health Inc |
| ELV - Elevance Health Inc | HOLD | 0 @ USD 424.53 | USD 0 | The current share valuation price of ELV based on adjusted close was USD 424.53. The average price that ELV shares were previous bought at was USD 408.28. The current market price is 4.0% higher than average price they were purchased at. The value of the holding in ELV has fallen by USD 513,203 compared to the previous valuation of Elevance Health Inc |
| COR - Cencora Inc. | HOLD | 0 @ USD 286.74 | USD 0 | The current share valuation price of COR based on adjusted close was USD 286.74. The average price that COR shares were previous bought at was USD 264.845. The current market price is 8.3% higher than average price they were purchased at. The value of the holding in COR has increased by USD 145,462 compared to the previous valuation of Cencora Inc. however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| EW - Edwards Lifesciences Corp | HOLD | 0 @ USD 71.53 | USD 0 | The current share valuation price of EW based on adjusted close was USD 71.53. The average price that EW shares were previous bought at was USD 71.264. The current market price is 0.4% higher than average price they were purchased at. The value of the holding in EW has increased by USD 55,007 compared to the previous valuation of Edwards Lifesciences Corp however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| A - Agilent Technologies Inc | HOLD | 0 @ USD 102.48 | USD 0 | The current share valuation price of A based on adjusted close was USD 102.48. The average price that A shares were previous bought at was USD 120.51. The current market price is -15.0% lower than average price they were purchased at. The value of the holding in A has fallen by USD 23,556 compared to the previous valuation of Agilent Technologies Inc |
| ALC.SW - | HOLD | 0 @ CHF 91.9324 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 91.9324. The average price that ALC.SW shares were previous bought at was CHF 88.6212. The current market price is 3.7% higher than average price they were purchased at. The value of the holding in ALC.SW has fallen by CHF 163,240 (USD $200,602) compared to the previous valuation of |
| 4568.T - Daiichi Sankyo Company, Limited | HOLD | 0 @ JPY 21.7972 | JPY 0 | The current share valuation price of 4568.T based on adjusted close was JPY 21.7972. The average price that 4568.T shares were previous bought at was JPY 29.4584. The current market price is -26.0% lower than average price they were purchased at. The value of the holding in 4568.T has fallen by JPY 55,071 (USD $388) compared to the previous valuation of Daiichi Sankyo Company, Limited |
| IQV - IQVIA Holdings Inc | HOLD | 0 @ USD 143.91 | USD 0 | The current share valuation price of IQV based on adjusted close was USD 143.91. The average price that IQV shares were previous bought at was USD 202.013. The current market price is -28.8% lower than average price they were purchased at. The value of the holding in IQV has fallen by USD 324,045 compared to the previous valuation of IQVIA Holdings Inc |
| VEEV - Veeva Systems Inc Class A | HOLD | 0 @ USD 215.95 | USD 0 | The current share valuation price of VEEV based on adjusted close was USD 215.95. The average price that VEEV shares were previous bought at was USD 240.61. The current market price is -10.2% lower than average price they were purchased at. The value of the holding in VEEV has fallen by USD 197,189 compared to the previous valuation of Veeva Systems Inc Class A |
| IDXX - IDEXX Laboratories Inc | HOLD | 0 @ USD 411.49 | USD 0 | The current share valuation price of IDXX based on adjusted close was USD 411.49. The average price that IDXX shares were previous bought at was USD 429.244. The current market price is -4.1% lower than average price they were purchased at. The value of the holding in IDXX has increased by USD 294,016 compared to the previous valuation of IDEXX Laboratories Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| 4519.T - Chugai Pharmaceutical Co., Ltd. | HOLD | 0 @ JPY 49.8172 | JPY 0 | The current share valuation price of 4519.T based on adjusted close was JPY 49.8172. The average price that 4519.T shares were previous bought at was JPY 46.9787. The current market price is 6.0% higher than average price they were purchased at. The value of the holding in 4519.T has increased by JPY 236,621 (USD $1,667) compared to the previous valuation of Chugai Pharmaceutical Co., Ltd. however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| CNC - Concurrent Technologies Plc | HOLD | 0 @ USD 60.7 | USD 0 | The current share valuation price of CNC based on adjusted close was USD 60.7. The average price that CNC shares were previous bought at was USD 58.94. The current market price is 3.0% higher than average price they were purchased at. The value of the holding in CNC has fallen by USD 229,081 compared to the previous valuation of Concurrent Technologies Plc |
| CAH - Cardinal Health Inc | HOLD | 0 @ USD 134.71 | USD 0 | The current share valuation price of CAH based on adjusted close was USD 134.71. The average price that CAH shares were previous bought at was USD 132.75. The current market price is 1.5% higher than average price they were purchased at. The value of the holding in CAH has increased by USD 33,384 compared to the previous valuation of Cardinal Health Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| UNH - UnitedHealth Group Incorporated | HOLD | 0 @ USD 454.11 | USD 0 | The current share valuation price of UNH based on adjusted close was USD 454.11. The average price that UNH shares were previous bought at was USD 532.16. The current market price is -14.7% lower than average price they were purchased at. The value of the holding in UNH has fallen by USD 5,816,434 compared to the previous valuation of UnitedHealth Group Incorporated |
| WAT - Waters Corporation | HOLD | 0 @ USD 321.01 | USD 0 | The current share valuation price of WAT based on adjusted close was USD 321.01. The average price that WAT shares were previous bought at was USD 368.53. The current market price is -12.9% lower than average price they were purchased at. The value of the holding in WAT has fallen by USD 2,106 compared to the previous valuation of Waters Corporation |
| WAT - MULETFWATIMETFP | HOLD | 0 @ USD 321.01 | USD 0 | The current share valuation price of WAT based on adjusted close was USD 321.01. The average price that WAT shares were previous bought at was USD 368.53. The current market price is -12.9% lower than average price they were purchased at. The value of the holding in WAT has fallen by USD 2,106 compared to the previous valuation of MULETFWATIMETFP |
| 4503.T - Astellas Pharma Inc. | HOLD | 0 @ JPY 9.33061 | JPY 0 | The current share valuation price of 4503.T based on adjusted close was JPY 9.33061. The average price that 4503.T shares were previous bought at was JPY 10.0154. The current market price is -6.8% lower than average price they were purchased at. The value of the holding in 4503.T has increased by JPY 35,835 (USD $252) compared to the previous valuation of Astellas Pharma Inc. however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| STE - STERIS plc | HOLD | 0 @ USD 222.23 | USD 0 | The current share valuation price of STE based on adjusted close was USD 222.23. The average price that STE shares were previous bought at was USD 216.443. The current market price is 2.7% higher than average price they were purchased at. The value of the holding in STE has increased by USD 85,976 compared to the previous valuation of STERIS plc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| MOH - MOH | HOLD | 0 @ USD 322.19 | USD 0 | The current share valuation price of MOH based on adjusted close was USD 322.19. The average price that MOH shares were previous bought at was USD 310.53. The current market price is 3.8% higher than average price they were purchased at. The value of the holding in MOH has fallen by USD 229,662 compared to the previous valuation of MOH |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | HOLD | 0 @ USD 322.19 | USD 0 | The current share valuation price of MOH based on adjusted close was USD 322.19. The average price that MOH shares were previous bought at was USD 310.53. The current market price is 3.8% higher than average price they were purchased at. The value of the holding in MOH has fallen by USD 229,662 compared to the previous valuation of LVMH Moët Hennessy - Louis Vuitton Société Européenne |
| HOLX - Hologic Inc | HOLD | 0 @ USD 57.56 | USD 0 | The current share valuation price of HOLX based on adjusted close was USD 57.56. The average price that HOLX shares were previous bought at was USD 65.168. The current market price is -11.7% lower than average price they were purchased at. The value of the holding in HOLX has increased by USD 94,804 compared to the previous valuation of Hologic Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| SOON.SW - | HOLD | 0 @ CHF 289.164 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 289.164. The average price that SOON.SW shares were previous bought at was CHF 303.951. The current market price is -4.9% lower than average price they were purchased at. The value of the holding in SOON.SW has increased by CHF 71,007 (USD $87,259) compared to the previous valuation of however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| JNJ - Johnson & Johnson | HOLD | 0 @ USD 157.47 | USD 0 | The current share valuation price of JNJ based on adjusted close was USD 157.47. The average price that JNJ shares were previous bought at was USD 161.02. The current market price is -2.2% lower than average price they were purchased at. The value of the holding in JNJ has increased by USD 172,009 compared to the previous valuation of Johnson & Johnson however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| ABBV - AbbVie Inc | HOLD | 0 @ USD 172.99 | USD 0 | The current share valuation price of ABBV based on adjusted close was USD 172.99. The average price that ABBV shares were previous bought at was USD 208.886. The current market price is -17.2% lower than average price they were purchased at. The value of the holding in ABBV has increased by USD 116,907 compared to the previous valuation of AbbVie Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| GMAB.CO - | HOLD | 0 @ DKK 196.318 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 196.318. The average price that GMAB.CO shares were previous bought at was DKK 191.375. The current market price is 2.6% higher than average price they were purchased at. The value of the holding in GMAB.CO has fallen by DKK 13,199 (USD $2,014) compared to the previous valuation of |
| AVTR - Avantor Inc | HOLD | 0 @ USD 15.1 | USD 0 | The current share valuation price of AVTR based on adjusted close was USD 15.1. The average price that AVTR shares were previous bought at was USD 20.7545. The current market price is -27.2% lower than average price they were purchased at. The value of the holding in AVTR has fallen by USD 40,234 compared to the previous valuation of Avantor Inc |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 133.976 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 133.976. The average price that AZN.L shares were previous bought at was GBP 131.564. The current market price is 1.8% higher than average price they were purchased at. The value of the holding in AZN.L has fallen by GBP 358,608 (USD $474,581) compared to the previous valuation of AstraZeneca PLC |
| COH.AX - | HOLD | 0 @ AUD 166.179 | AUD 0 | The current share valuation price of COH.AX based on adjusted close was AUD 166.179. The average price that COH.AX shares were previous bought at was AUD 168.107. The current market price is -1.1% lower than average price they were purchased at. The value of the holding in COH.AX has increased by AUD 18,216 (USD $11,609) compared to the previous valuation of however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| MRK - Marks Electrical Group PLC | HOLD | 0 @ USD 78 | USD 0 | The current share valuation price of MRK based on adjusted close was USD 78. The average price that MRK shares were previous bought at was USD 99.9826. The current market price is -22.0% lower than average price they were purchased at. The value of the holding in MRK has increased by USD 78,830 compared to the previous valuation of Marks Electrical Group PLC however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| MRK - Merck & Company Inc | HOLD | 0 @ USD 78 | USD 0 | The current share valuation price of MRK based on adjusted close was USD 78. The average price that MRK shares were previous bought at was USD 99.9826. The current market price is -22.0% lower than average price they were purchased at. The value of the holding in MRK has increased by USD 78,830 compared to the previous valuation of Merck & Company Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| ROG.SW - | HOLD | 0 @ CHF 311.726 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 311.726. The average price that ROG.SW shares were previous bought at was CHF 346.579. The current market price is -10.1% lower than average price they were purchased at. The value of the holding in ROG.SW has fallen by CHF 3,530 (USD $4,338) compared to the previous valuation of |
| TMO - Time Out Group plc | HOLD | 0 @ USD 427.5 | USD 0 | The current share valuation price of TMO based on adjusted close was USD 427.5. The average price that TMO shares were previous bought at was USD 546.711. The current market price is -21.8% lower than average price they were purchased at. The value of the holding in TMO has fallen by USD 71,644 compared to the previous valuation of Time Out Group plc |
| 6869.T - Sysmex Corporation | HOLD | 0 @ JPY 18.8687 | JPY 0 | The current share valuation price of 6869.T based on adjusted close was JPY 18.8687. The average price that 6869.T shares were previous bought at was JPY 18.7521. The current market price is 0.6% higher than average price they were purchased at. The value of the holding in 6869.T has fallen by JPY 21,761 (USD $153) compared to the previous valuation of Sysmex Corporation |
| ABT - Abbott Laboratories | HOLD | 0 @ USD 130.98 | USD 0 | The current share valuation price of ABT based on adjusted close was USD 130.98. The average price that ABT shares were previous bought at was USD 125.6. The current market price is 4.3% higher than average price they were purchased at. The value of the holding in ABT has increased by USD 44,976 compared to the previous valuation of Abbott Laboratories however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| ISRG - Intuitive Surgical Inc | HOLD | 0 @ USD 482.74 | USD 0 | The current share valuation price of ISRG based on adjusted close was USD 482.74. The average price that ISRG shares were previous bought at was USD 519.81. The current market price is -7.1% lower than average price they were purchased at. The value of the holding in ISRG has increased by USD 10,042 compared to the previous valuation of Intuitive Surgical Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| DVA - DaVita HealthCare Partners Inc | HOLD | 0 @ USD 140.03 | USD 0 | The current share valuation price of DVA based on adjusted close was USD 140.03. The average price that DVA shares were previous bought at was USD 150.78. The current market price is -7.1% lower than average price they were purchased at. The value of the holding in DVA has fallen by USD 1,835 compared to the previous valuation of DaVita HealthCare Partners Inc |
| 4523.T - Eisai Co., Ltd. | HOLD | 0 @ JPY 27.3379 | JPY 0 | The current share valuation price of 4523.T based on adjusted close was JPY 27.3379. The average price that 4523.T shares were previous bought at was JPY 28.829. The current market price is -5.2% lower than average price they were purchased at. The value of the holding in 4523.T has increased by JPY 22,082 (USD $156) compared to the previous valuation of Eisai Co., Ltd. however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| DHR - Danaher Corporation | HOLD | 0 @ USD 186.83 | USD 0 | The current share valuation price of DHR based on adjusted close was USD 186.83. The average price that DHR shares were previous bought at was USD 212.4. The current market price is -12.0% lower than average price they were purchased at. The value of the holding in DHR has fallen by USD 50,196 compared to the previous valuation of Danaher Corporation |
| DHR - Danaher Corporation | HOLD | 0 @ USD 186.83 | USD 0 | The current share valuation price of DHR based on adjusted close was USD 186.83. The average price that DHR shares were previous bought at was USD 212.4. The current market price is -12.0% lower than average price they were purchased at. The value of the holding in DHR has fallen by USD 50,196 compared to the previous valuation of Danaher Corporation |
| PFE - Pfizer Inc | HOLD | 0 @ USD 22.14 | USD 0 | The current share valuation price of PFE based on adjusted close was USD 22.14. The average price that PFE shares were previous bought at was USD 25.55. The current market price is -13.3% lower than average price they were purchased at. The value of the holding in PFE has increased by USD 11,359 compared to the previous valuation of Pfizer Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| SYK - Stryker Corporation | HOLD | 0 @ USD 346.5 | USD 0 | The current share valuation price of SYK based on adjusted close was USD 346.5. The average price that SYK shares were previous bought at was USD 372.87. The current market price is -7.1% lower than average price they were purchased at. The value of the holding in SYK has fallen by USD 1,166 compared to the previous valuation of Stryker Corporation |
| BSX - Boston Scientific Corporation | HOLD | 0 @ USD 95.12 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 95.12. The average price that BSX shares were previous bought at was USD 103.08. The current market price is -7.7% lower than average price they were purchased at. The value of the holding in BSX has fallen by USD 3,857 compared to the previous valuation of Boston Scientific Corporation |
| BSX - MULSTRXSSXIMETFP | HOLD | 0 @ USD 95.12 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 95.12. The average price that BSX shares were previous bought at was USD 103.08. The current market price is -7.7% lower than average price they were purchased at. The value of the holding in BSX has fallen by USD 3,857 compared to the previous valuation of MULSTRXSSXIMETFP |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 237.225 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 237.225. The average price that SRT3.DE shares were previous bought at was EUR 250.356. The current market price is -5.2% lower than average price they were purchased at. The value of the holding in SRT3.DE has fallen by EUR 65,687 (USD $74,862) compared to the previous valuation of Sartorius AG |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 154.707 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 154.707. The average price that UCB.BR shares were previous bought at was EUR 193.113. The current market price is -19.9% lower than average price they were purchased at. The value of the holding in UCB.BR has fallen by EUR 68,974 (USD $78,608) compared to the previous valuation of UCB SA |
| MRNA - Moderna Inc | HOLD | 0 @ USD 24.715 | USD 0 | The current share valuation price of MRNA based on adjusted close was USD 24.715. The average price that MRNA shares were previous bought at was USD 42.9847. The current market price is -42.5% lower than average price they were purchased at. The value of the holding in MRNA has fallen by USD 28,634 compared to the previous valuation of Moderna Inc |
| BMY - Bloomsbury Publishing Plc | HOLD | 0 @ USD 49.23 | USD 0 | The current share valuation price of BMY based on adjusted close was USD 49.23. The average price that BMY shares were previous bought at was USD 59.19. The current market price is -16.8% lower than average price they were purchased at. The value of the holding in BMY has fallen by USD 5,298 compared to the previous valuation of Bloomsbury Publishing Plc |
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 102.96 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 102.96. The average price that SAN.PA shares were previous bought at was EUR 112.023. The current market price is -8.1% lower than average price they were purchased at. The value of the holding in SAN.PA has increased by EUR 1,701 (USD $1,939) compared to the previous valuation of Sanofi SA however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| MDT - Medtronic PLC | HOLD | 0 @ USD 82.6 | USD 0 | The current share valuation price of MDT based on adjusted close was USD 82.6. The average price that MDT shares were previous bought at was USD 88.59. The current market price is -6.8% lower than average price they were purchased at. The value of the holding in MDT has fallen by USD 2,587 compared to the previous valuation of Medtronic PLC |
| HUM - Hummingbird Resources PLC | HOLD | 0 @ USD 264.48 | USD 0 | The current share valuation price of HUM based on adjusted close was USD 264.48. The average price that HUM shares were previous bought at was USD 303.923. The current market price is -13.0% lower than average price they were purchased at. The value of the holding in HUM has fallen by USD 625,026 compared to the previous valuation of Hummingbird Resources PLC |
| HUM - Humana Inc | HOLD | 0 @ USD 264.48 | USD 0 | The current share valuation price of HUM based on adjusted close was USD 264.48. The average price that HUM shares were previous bought at was USD 303.923. The current market price is -13.0% lower than average price they were purchased at. The value of the holding in HUM has fallen by USD 625,026 compared to the previous valuation of Humana Inc |
| CSL.AX - | HOLD | 0 @ AUD 152.394 | AUD 0 | The current share valuation price of CSL.AX based on adjusted close was AUD 152.394. The average price that CSL.AX shares were previous bought at was AUD 161.977. The current market price is -5.9% lower than average price they were purchased at. The value of the holding in CSL.AX has fallen by AUD 19,097 (USD $12,171) compared to the previous valuation of |
| REGN - Regeneron Pharmaceuticals Inc | HOLD | 0 @ USD 563.16 | USD 0 | The current share valuation price of REGN based on adjusted close was USD 563.16. The average price that REGN shares were previous bought at was USD 634.14. The current market price is -11.2% lower than average price they were purchased at. The value of the holding in REGN has increased by USD 30,272 compared to the previous valuation of Regeneron Pharmaceuticals Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| LH - Laboratory Corporation of America Holdings | HOLD | 0 @ USD 217.12 | USD 0 | The current share valuation price of LH based on adjusted close was USD 217.12. The average price that LH shares were previous bought at was USD 234.45. The current market price is -7.4% lower than average price they were purchased at. The value of the holding in LH has fallen by USD 5,817 compared to the previous valuation of Laboratory Corporation of America Holdings |
| 4151.T - Kyowa Kirin Co., Ltd. | HOLD | 0 @ JPY 15.4268 | JPY 0 | The current share valuation price of 4151.T based on adjusted close was JPY 15.4268. The average price that 4151.T shares were previous bought at was JPY 14.5256. The current market price is 6.2% higher than average price they were purchased at. The value of the holding in 4151.T has fallen by JPY 3,011 (USD $21) compared to the previous valuation of Kyowa Kirin Co., Ltd. |
| DEMANT.CO - | HOLD | 0 @ DKK 33.989 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 33.989. The average price that DEMANT.CO shares were previous bought at was DKK 36.7116. The current market price is -7.4% lower than average price they were purchased at. The value of the holding in DEMANT.CO has fallen by DKK 3,285 (USD $501) compared to the previous valuation of |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 17.6866 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 17.6866. The average price that GSK.L shares were previous bought at was GBP 19.24. The current market price is -8.1% lower than average price they were purchased at. The value of the holding in GSK.L has fallen by GBP 12,478 (USD $16,513) compared to the previous valuation of GlaxoSmithKline PLC |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 280.698 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 280.698. The average price that EL.PA shares were previous bought at was EUR 299.39. The current market price is -6.2% lower than average price they were purchased at. The value of the holding in EL.PA has fallen by EUR 21,677 (USD $24,705) compared to the previous valuation of EssilorLuxottica SA |
| HCA - HCA Holdings Inc | HOLD | 0 @ USD 335.01 | USD 0 | The current share valuation price of HCA based on adjusted close was USD 335.01. The average price that HCA shares were previous bought at was USD 336.46. The current market price is -0.4% lower than average price they were purchased at. The value of the holding in HCA has increased by USD 15,904 compared to the previous valuation of HCA Holdings Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| CVS - CVS Health Corp | HOLD | 0 @ USD 67.29 | USD 0 | The current share valuation price of CVS based on adjusted close was USD 67.29. The average price that CVS shares were previous bought at was USD 66.48. The current market price is 1.2% higher than average price they were purchased at. The value of the holding in CVS has fallen by USD 31,493 compared to the previous valuation of CVS Health Corp |
| BDX - Becton Dickinson and Company | HOLD | 0 @ USD 198.71 | USD 0 | The current share valuation price of BDX based on adjusted close was USD 198.71. The average price that BDX shares were previous bought at was USD 228.08. The current market price is -12.9% lower than average price they were purchased at. The value of the holding in BDX has fallen by USD 9,773 compared to the previous valuation of Becton Dickinson and Company |
| AMP.MI - Amplifon SpA | HOLD | 0 @ EUR 18.3992 | EUR 0 | The current share valuation price of AMP.MI based on adjusted close was EUR 18.3992. The average price that AMP.MI shares were previous bought at was EUR 21.2932. The current market price is -13.6% lower than average price they were purchased at. The value of the holding in AMP.MI has fallen by EUR 6,010 (USD $6,849) compared to the previous valuation of Amplifon SpA |
| LONN.SW - | HOLD | 0 @ CHF 657.601 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 657.601. The average price that LONN.SW shares were previous bought at was CHF 646.902. The current market price is 1.7% higher than average price they were purchased at. The value of the holding in LONN.SW has fallen by CHF 9,635 (USD $11,840) compared to the previous valuation of |
| 4502.T - Takeda Pharmaceutical Company Limited | HOLD | 0 @ JPY 29.3067 | JPY 0 | The current share valuation price of 4502.T based on adjusted close was JPY 29.3067. The average price that 4502.T shares were previous bought at was JPY 30.3465. The current market price is -3.4% lower than average price they were purchased at. The value of the holding in 4502.T has fallen by JPY 3,075 (USD $22) compared to the previous valuation of Takeda Pharmaceutical Company Limited |
| 7741.T - HOYA Corporation | HOLD | 0 @ JPY 108.564 | JPY 0 | The current share valuation price of 7741.T based on adjusted close was JPY 108.564. The average price that 7741.T shares were previous bought at was JPY 127.799. The current market price is -15.1% lower than average price they were purchased at. The value of the holding in 7741.T has increased by JPY 7,442 (USD $52) compared to the previous valuation of HOYA Corporation however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| GEHC - GE HealthCare Technologies Inc. | HOLD | 0 @ USD 62.37 | USD 0 | The current share valuation price of GEHC based on adjusted close was USD 62.37. The average price that GEHC shares were previous bought at was USD 86.2181. The current market price is -27.7% lower than average price they were purchased at. The value of the holding in GEHC has increased by USD 8,400 compared to the previous valuation of GE HealthCare Technologies Inc. however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| RMD - ResMed Inc | HOLD | 0 @ USD 212.91 | USD 0 | The current share valuation price of RMD based on adjusted close was USD 212.91. The average price that RMD shares were previous bought at was USD 221.29. The current market price is -3.8% lower than average price they were purchased at. The value of the holding in RMD has increased by USD 4,192 compared to the previous valuation of ResMed Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 594.993 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 594.993. The average price that ARGX.BR shares were previous bought at was EUR 603.748. The current market price is -1.5% lower than average price they were purchased at. The value of the holding in ARGX.BR has fallen by EUR 938 (USD $1,069) compared to the previous valuation of Argenx SE |
| ALNY - Alnylam Pharmaceuticals Inc | HOLD | 0 @ USD 234.56 | USD 0 | The current share valuation price of ALNY based on adjusted close was USD 234.56. The average price that ALNY shares were previous bought at was USD 280.96. The current market price is -16.5% lower than average price they were purchased at. The value of the holding in ALNY has increased by USD 10,166 compared to the previous valuation of Alnylam Pharmaceuticals Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| DXCM - DexCom Inc | HOLD | 0 @ USD 68.57 | USD 0 | The current share valuation price of DXCM based on adjusted close was USD 68.57. The average price that DXCM shares were previous bought at was USD 73.55. The current market price is -6.8% lower than average price they were purchased at. The value of the holding in DXCM has fallen by USD 1,242 compared to the previous valuation of DexCom Inc |
| MTD - Mettler-Toledo International Inc | HOLD | 0 @ USD 1004.96 | USD 0 | The current share valuation price of MTD based on adjusted close was USD 1004.96. The average price that MTD shares were previous bought at was USD 1195.1. The current market price is -15.9% lower than average price they were purchased at. The value of the holding in MTD has fallen by USD 5,295 compared to the previous valuation of Mettler-Toledo International Inc |
| MTD - AMUNDI EUR GOV 710 | HOLD | 0 @ USD 1004.96 | USD 0 | The current share valuation price of MTD based on adjusted close was USD 1004.96. The average price that MTD shares were previous bought at was USD 1195.1. The current market price is -15.9% lower than average price they were purchased at. The value of the holding in MTD has fallen by USD 5,295 compared to the previous valuation of AMUNDI EUR GOV 710 |
| 4543.T - Terumo Corporation | HOLD | 0 @ JPY 19.0409 | JPY 0 | The current share valuation price of 4543.T based on adjusted close was JPY 19.0409. The average price that 4543.T shares were previous bought at was JPY 18.7688. The current market price is 1.4% higher than average price they were purchased at. The value of the holding in 4543.T has increased by JPY 17,984 (USD $127) compared to the previous valuation of Terumo Corporation however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| BIIB - Biogen Inc | HOLD | 0 @ USD 118.61 | USD 0 | The current share valuation price of BIIB based on adjusted close was USD 118.61. The average price that BIIB shares were previous bought at was USD 139.16. The current market price is -14.8% lower than average price they were purchased at. The value of the holding in BIIB has increased by USD 9,837 compared to the previous valuation of Biogen Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| 4578.T - Otsuka Holdings Co., Ltd. | HOLD | 0 @ JPY 47.8133 | JPY 0 | The current share valuation price of 4578.T based on adjusted close was JPY 47.8133. The average price that 4578.T shares were previous bought at was JPY 56.84. The current market price is -15.9% lower than average price they were purchased at. The value of the holding in 4578.T has increased by JPY 2,659 (USD $19) compared to the previous valuation of Otsuka Holdings Co., Ltd. however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| WST - West Pharmaceutical Services Inc | HOLD | 0 @ USD 201.9 | USD 0 | The current share valuation price of WST based on adjusted close was USD 201.9. The average price that WST shares were previous bought at was USD 225.8. The current market price is -10.6% lower than average price they were purchased at. The value of the holding in WST has fallen by USD 10,794 compared to the previous valuation of West Pharmaceutical Services Inc |
| ILMN - Illumina Inc | HOLD | 0 @ USD 71.2001 | USD 0 | The current share valuation price of ILMN based on adjusted close was USD 71.2001. The average price that ILMN shares were previous bought at was USD 87.5299. The current market price is -18.7% lower than average price they were purchased at. The value of the holding in ILMN has fallen by USD 7,325 compared to the previous valuation of Illumina Inc |
| ZBH - Zimmer Biomet Holdings Inc | HOLD | 0 @ USD 97.92 | USD 0 | The current share valuation price of ZBH based on adjusted close was USD 97.92. The average price that ZBH shares were previous bought at was USD 110.38. The current market price is -11.3% lower than average price they were purchased at. The value of the holding in ZBH has increased by USD 4,115 compared to the previous valuation of Zimmer Biomet Holdings Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 23.8701 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 23.8701. The average price that BAYN.DE shares were previous bought at was EUR 25.4568. The current market price is -6.2% lower than average price they were purchased at. The value of the holding in BAYN.DE has increased by EUR 350 (USD $399) compared to the previous valuation of Bayer AG however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 23.768 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 23.768. The average price that PHIA.AS shares were previous bought at was EUR 25.608. The current market price is -7.2% lower than average price they were purchased at. The value of the holding in PHIA.AS has fallen by EUR 5,586 (USD $6,366) compared to the previous valuation of Koninklijke Philips NV |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 132.403 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 132.403. The average price that MRK.DE shares were previous bought at was EUR 141.271. The current market price is -6.3% lower than average price they were purchased at. The value of the holding in MRK.DE has fallen by EUR 6,837 (USD $7,792) compared to the previous valuation of Merck KGaA |
| COO - The Cooper Companies, Inc. Common Stock | HOLD | 0 @ USD 79.5101 | USD 0 | The current share valuation price of COO based on adjusted close was USD 79.5101. The average price that COO shares were previous bought at was USD 83.7001. The current market price is -5.0% lower than average price they were purchased at. The value of the holding in COO has increased by USD 5,147 compared to the previous valuation of The Cooper Companies, Inc. Common Stock however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| 7733.T - Olympus Corporation | HOLD | 0 @ JPY 12.565 | JPY 0 | The current share valuation price of 7733.T based on adjusted close was JPY 12.565. The average price that 7733.T shares were previous bought at was JPY 13.5641. The current market price is -7.4% lower than average price they were purchased at. The value of the holding in 7733.T has increased by JPY 3,812 (USD $27) compared to the previous valuation of Olympus Corporation however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| PODD - Insulet Corporation | HOLD | 0 @ USD 246.8 | USD 0 | The current share valuation price of PODD based on adjusted close was USD 246.8. The average price that PODD shares were previous bought at was USD 272.71. The current market price is -9.5% lower than average price they were purchased at. The value of the holding in PODD has fallen by USD 5,577 compared to the previous valuation of Insulet Corporation |
| TEVA - Teva Pharma Industries Ltd ADR | HOLD | 0 @ USD 13.65 | USD 0 | The current share valuation price of TEVA based on adjusted close was USD 13.65. The average price that TEVA shares were previous bought at was USD 15.7. The current market price is -13.1% lower than average price they were purchased at. The value of the holding in TEVA has increased by USD 4,878 compared to the previous valuation of Teva Pharma Industries Ltd ADR however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| SDZ.SW - | HOLD | 0 @ CHF 39.6731 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 39.6731. The average price that SDZ.SW shares were previous bought at was CHF 43.5349. The current market price is -8.9% lower than average price they were purchased at. The value of the holding in SDZ.SW has fallen by CHF 7,074 (USD $8,693) compared to the previous valuation of |
| BAX - Baxter International Inc | HOLD | 0 @ USD 28.89 | USD 0 | The current share valuation price of BAX based on adjusted close was USD 28.89. The average price that BAX shares were previous bought at was USD 32.94. The current market price is -12.3% lower than average price they were purchased at. The value of the holding in BAX has increased by USD 11,348 compared to the previous valuation of Baxter International Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| UTHR - United Therapeutics Corporation | HOLD | 0 @ USD 284.73 | USD 0 | The current share valuation price of UTHR based on adjusted close was USD 284.73. The average price that UTHR shares were previous bought at was USD 316.73. The current market price is -10.1% lower than average price they were purchased at. The value of the holding in UTHR has fallen by USD 414 compared to the previous valuation of United Therapeutics Corporation |
| DGX - Quest Diagnostics Incorporated | HOLD | 0 @ USD 163.8 | USD 0 | The current share valuation price of DGX based on adjusted close was USD 163.8. The average price that DGX shares were previous bought at was USD 165.66. The current market price is -1.1% lower than average price they were purchased at. The value of the holding in DGX has fallen by USD 1,481 compared to the previous valuation of Quest Diagnostics Incorporated |
| RVTY - Revvity Inc. | HOLD | 0 @ USD 91.82 | USD 0 | The current share valuation price of RVTY based on adjusted close was USD 91.82. The average price that RVTY shares were previous bought at was USD 107.38. The current market price is -14.5% lower than average price they were purchased at. The value of the holding in RVTY has fallen by USD 5,146 compared to the previous valuation of Revvity Inc. |
| ALGN - Align Technology Inc | HOLD | 0 @ USD 171.41 | USD 0 | The current share valuation price of ALGN based on adjusted close was USD 171.41. The average price that ALGN shares were previous bought at was USD 170. The current market price is 0.8% higher than average price they were purchased at. The value of the holding in ALGN has increased by USD 6,192 compared to the previous valuation of Align Technology Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| VTRS - Viatris Inc | HOLD | 0 @ USD 7.56002 | USD 0 | The current share valuation price of VTRS based on adjusted close was USD 7.56002. The average price that VTRS shares were previous bought at was USD 8.95. The current market price is -15.5% lower than average price they were purchased at. The value of the holding in VTRS has increased by USD 4,013 compared to the previous valuation of Viatris Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| INCY - Incyte Corporation | HOLD | 0 @ USD 58.2099 | USD 0 | The current share valuation price of INCY based on adjusted close was USD 58.2099. The average price that INCY shares were previous bought at was USD 62.0799. The current market price is -6.2% lower than average price they were purchased at. The value of the holding in INCY has increased by USD 1,477 compared to the previous valuation of Incyte Corporation however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 50.6914 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 50.6914. The average price that SHL.DE shares were previous bought at was EUR 56.0978. The current market price is -9.6% lower than average price they were purchased at. The value of the holding in SHL.DE has fallen by EUR 2,873 (USD $3,274) compared to the previous valuation of Siemens Healthineers AG |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 44.2783 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 44.2783. The average price that FRE.DE shares were previous bought at was EUR 43.1589. The current market price is 2.6% higher than average price they were purchased at. The value of the holding in FRE.DE has fallen by EUR 5,591 (USD $6,372) compared to the previous valuation of Fresenius SE & Co KGaA |
| STMN.SW - | HOLD | 0 @ CHF 118.202 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 118.202. The average price that STMN.SW shares were previous bought at was CHF 128.904. The current market price is -8.3% lower than average price they were purchased at. The value of the holding in STMN.SW has increased by CHF 2,440 (USD $2,998) compared to the previous valuation of however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| PME.AX - | HOLD | 0 @ AUD 131.905 | AUD 0 | The current share valuation price of PME.AX based on adjusted close was AUD 131.905. The average price that PME.AX shares were previous bought at was AUD 145.003. The current market price is -9.0% lower than average price they were purchased at. The value of the holding in PME.AX has increased by AUD 2,537 (USD $1,617) compared to the previous valuation of however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| FPH.NZ - | HOLD | 0 @ NZD 19.961 | NZD 0 | The current share valuation price of FPH.NZ based on adjusted close was NZD 19.961. The average price that FPH.NZ shares were previous bought at was NZD 18.9648. The current market price is 5.3% higher than average price they were purchased at. The value of the holding in FPH.NZ has increased by NZD 685 (USD $407) compared to the previous valuation of however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 9.15758 | EUR 0 | |
| NBIX - Neurocrine Biosciences Inc | HOLD | 0 @ USD 101.38 | USD 0 | The current share valuation price of NBIX based on adjusted close was USD 101.38. The average price that NBIX shares were previous bought at was USD 116.18. The current market price is -12.7% lower than average price they were purchased at. The value of the holding in NBIX has increased by USD 2,387 compared to the previous valuation of Neurocrine Biosciences Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| BMRN - Biomarin Pharmaceutical Inc | HOLD | 0 @ USD 59.1701 | USD 0 | The current share valuation price of BMRN based on adjusted close was USD 59.1701. The average price that BMRN shares were previous bought at was USD 71.5301. The current market price is -17.3% lower than average price they were purchased at. The value of the holding in BMRN has increased by USD 1,227 compared to the previous valuation of Biomarin Pharmaceutical Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 129.055 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 129.055. The average price that BIM.PA shares were previous bought at was EUR 126.906. The current market price is 1.7% higher than average price they were purchased at. The value of the holding in BIM.PA has fallen by EUR 11,636 (USD $13,261) compared to the previous valuation of BioMerieux |
| SOLV - Solventum Corp. | HOLD | 0 @ USD 66.2601 | USD 0 | The current share valuation price of SOLV based on adjusted close was USD 66.2601. The average price that SOLV shares were previous bought at was USD 74.9301. The current market price is -11.6% lower than average price they were purchased at. The value of the holding in SOLV has increased by USD 1,865 compared to the previous valuation of Solventum Corp. however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| DIA.MI - DiaSorin SpA | HOLD | 0 @ EUR 111.144 | EUR 0 | The current share valuation price of DIA.MI based on adjusted close was EUR 111.144. The average price that DIA.MI shares were previous bought at was EUR 102.54. The current market price is 8.4% higher than average price they were purchased at. The value of the holding in DIA.MI has increased by EUR 213,397 (USD $243,204) compared to the previous valuation of DiaSorin SpA however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| TECH - Bio-Techne Corp | HOLD | 0 @ USD 48.0999 | USD 0 | The current share valuation price of TECH based on adjusted close was USD 48.0999. The average price that TECH shares were previous bought at was USD 59.9802. The current market price is -19.8% lower than average price they were purchased at. The value of the holding in TECH has fallen by USD 5,481 compared to the previous valuation of Bio-Techne Corp |
| RO.SW - | HOLD | 0 @ CHF 329.045 | CHF 0 | The current share valuation price of RO.SW based on adjusted close was CHF 329.045. The average price that RO.SW shares were previous bought at was CHF 366.42. The current market price is -10.2% lower than average price they were purchased at. The value of the holding in RO.SW has fallen by CHF 396 (USD $487) compared to the previous valuation of |
| BIO - Bio-Rad Laboratories Inc | HOLD | 0 @ USD 238.18 | USD 0 | The current share valuation price of BIO based on adjusted close was USD 238.18. The average price that BIO shares were previous bought at was USD 247.31. The current market price is -3.7% lower than average price they were purchased at. The value of the holding in BIO has fallen by USD 4,148 compared to the previous valuation of Bio-Rad Laboratories Inc |
| BIO - Biotest Aktiengesellschaft | HOLD | 0 @ USD 238.18 | USD 0 | The current share valuation price of BIO based on adjusted close was USD 238.18. The average price that BIO shares were previous bought at was USD 247.31. The current market price is -3.7% lower than average price they were purchased at. The value of the holding in BIO has fallen by USD 4,148 compared to the previous valuation of Biotest Aktiengesellschaft |
| RPRX - Royalty Pharma Plc | HOLD | 0 @ USD 32.6 | USD 0 | The current share valuation price of RPRX based on adjusted close was USD 32.6. The average price that RPRX shares were previous bought at was USD 33.76. The current market price is -3.4% lower than average price they were purchased at. The value of the holding in RPRX has increased by USD 3,364 compared to the previous valuation of Royalty Pharma Plc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| 4507.T - Shionogi & Co., Ltd. | HOLD | 0 @ JPY 16.6432 | JPY 0 | The current share valuation price of 4507.T based on adjusted close was JPY 16.6432. The average price that 4507.T shares were previous bought at was JPY 15.5539. The current market price is 7.0% higher than average price they were purchased at. The value of the holding in 4507.T has increased by JPY 5,233 (USD $37) compared to the previous valuation of Shionogi & Co., Ltd. however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 13.0165 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 13.0165. The average price that SN.L shares were previous bought at was GBP 14.1581. The current market price is -8.1% lower than average price they were purchased at. The value of the holding in SN.L has fallen by GBP 777 (USD $1,028) compared to the previous valuation of Smith & Nephew PLC |
| SOBI.ST - | HOLD | 0 @ SEK 27.2705 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 27.2705. The average price that SOBI.ST shares were previous bought at was SEK 28.8694. The current market price is -5.5% lower than average price they were purchased at. The value of the holding in SOBI.ST has increased by SEK 3,068 (USD $315) compared to the previous valuation of however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| SHL.AX - | HOLD | 0 @ AUD 16.1594 | AUD 0 | The current share valuation price of SHL.AX based on adjusted close was AUD 16.1594. The average price that SHL.AX shares were previous bought at was AUD 16.2229. The current market price is -0.4% lower than average price they were purchased at. The value of the holding in SHL.AX has increased by AUD 164 (USD $105) compared to the previous valuation of however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| HIK.L - | HOLD | 0 @ GBP 24.9451 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 24.9451. The average price that HIK.L shares were previous bought at was GBP 25.9727. The current market price is -4.0% lower than average price they were purchased at. The value of the holding in HIK.L has fallen by GBP 1,027 (USD $1,359) compared to the previous valuation of |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 47.1955 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 47.1955. The average price that FME.DE shares were previous bought at was EUR 49.0344. The current market price is -3.8% lower than average price they were purchased at. The value of the holding in FME.DE has fallen by EUR 13,432 (USD $15,308) compared to the previous valuation of Fresenius Medical Care AG |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 212.425 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 212.425. The average price that DIM.PA shares were previous bought at was EUR 208.558. The current market price is 1.9% higher than average price they were purchased at. The value of the holding in DIM.PA has fallen by EUR 4,965 (USD $5,659) compared to the previous valuation of Sartorius Stedim Biotech |
| 2413.T - M3, Inc. | HOLD | 0 @ JPY 12.3541 | JPY 0 | The current share valuation price of 2413.T based on adjusted close was JPY 12.3541. The average price that 2413.T shares were previous bought at was JPY 11.3307. The current market price is 9.0% higher than average price they were purchased at. The value of the holding in 2413.T has increased by JPY 16,808 (USD $118) compared to the previous valuation of M3, Inc. however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 55.7083 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 55.7083. The average price that ORNBV.HE shares were previous bought at was EUR 60.5692. The current market price is -8.0% lower than average price they were purchased at. The value of the holding in ORNBV.HE has fallen by EUR 1,706 (USD $1,944) compared to the previous valuation of Orion Oyj |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 102.949 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 102.949. The average price that IPN.PA shares were previous bought at was EUR 117.51. The current market price is -12.4% lower than average price they were purchased at. The value of the holding in IPN.PA has fallen by EUR 7,529 (USD $8,581) compared to the previous valuation of Ipsen SA |
| ZEAL.CO - | HOLD | 0 @ DKK 64.5274 | DKK 0 | The current share valuation price of ZEAL.CO based on adjusted close was DKK 64.5274. The average price that ZEAL.CO shares were previous bought at was DKK 95.1384. The current market price is -32.2% lower than average price they were purchased at. The value of the holding in ZEAL.CO has fallen by DKK 342 (USD $52) compared to the previous valuation of |
| EXAS - EXACT Sciences Corporation | HOLD | 0 @ USD 41.58 | USD 0 | The current share valuation price of EXAS based on adjusted close was USD 41.58. The average price that EXAS shares were previous bought at was USD 54.275. The current market price is -23.4% lower than average price they were purchased at. The value of the holding in EXAS has fallen by USD 2,921 compared to the previous valuation of EXACT Sciences Corporation |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 54.8911 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 54.8911. The average price that REC.MI shares were previous bought at was EUR 58.2146. The current market price is -5.7% lower than average price they were purchased at. The value of the holding in REC.MI has fallen by EUR 975 (USD $1,111) compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA |
| 4528.T - Ono Pharmaceutical Co., Ltd. | HOLD | 0 @ JPY 12.0377 | JPY 0 | The current share valuation price of 4528.T based on adjusted close was JPY 12.0377. The average price that 4528.T shares were previous bought at was JPY 11.1277. The current market price is 8.2% higher than average price they were purchased at. The value of the holding in 4528.T has fallen by JPY 8 (USD $0) compared to the previous valuation of Ono Pharmaceutical Co., Ltd. |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 56.2643 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 56.2643. The average price that ERF.PA shares were previous bought at was EUR 49.8168. The current market price is 12.9% higher than average price they were purchased at. The value of the holding in ERF.PA has fallen by EUR 5,198 (USD $5,924) compared to the previous valuation of Eurofins Scientific SE |
| GALD.SW - | HOLD | 0 @ CHF 95.7985 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 95.7985. The average price that GALD.SW shares were previous bought at was CHF 108.577. The current market price is -11.8% lower than average price they were purchased at. The value of the holding in GALD.SW has fallen by CHF 586 (USD $720) compared to the previous valuation of |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 64.0334 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 64.0334. The average price that NOVO-B.CO shares were previous bought at was DKK 75.4683. The current market price is -15.2% lower than average price they were purchased at. The value of the holding in NOVO-B.CO has fallen by DKK 63,935 (USD $9,758) compared to the previous valuation of Novo Nordisk A/S |
| COLO-B.CO - | HOLD | 0 @ DKK 106.77 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 106.77. The average price that COLO-B.CO shares were previous bought at was DKK 105.502. The current market price is 1.2% higher than average price they were purchased at. The value of the holding in COLO-B.CO has fallen by DKK 14,398 (USD $2,197) compared to the previous valuation of |
| QIA.DE - QIAGEN NV | HOLD | 0 @ EUR 40.8391 | EUR 0 | The current share valuation price of QIA.DE based on adjusted close was EUR 40.8391. The average price that QIA.DE shares were previous bought at was EUR 39.708. The current market price is 2.8% higher than average price they were purchased at. The value of the holding in QIA.DE has fallen by EUR 77,509 (USD $88,335) compared to the previous valuation of QIAGEN NV |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 5.03535 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 5.03535. The average price that HLN.L shares were previous bought at was GBP 4.94853. The current market price is 1.8% higher than average price they were purchased at. The value of the holding in HLN.L has fallen by GBP 6,582 (USD $8,711) compared to the previous valuation of Haleon PLC |
| NTRA - Natera Inc | HOLD | 0 @ USD 148.08 | USD 0 | The current share valuation price of NTRA based on adjusted close was USD 148.08. The average price that NTRA shares were previous bought at was USD 154.58. The current market price is -4.2% lower than average price they were purchased at. The value of the holding in NTRA has fallen by USD 5,162 compared to the previous valuation of Natera Inc |